This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Plexus price target raised to $220 from $195 at Benchmark
Benchmark raised the firm’s price target on Plexus (PLXS) to $220 from $195 and keeps a Buy rating on the shares following stronger-than-expected results. While “constructive” heading into the print, the firm says it was “still surprised” by the strength of the Q2 guidance and “the more upbeat tone” around demand momentum for the balance of FY26 and beyond.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PLXS:
Disclaimer & DisclosureReport an Issue
- Plexus price target raised to $200 from $150 at Stifel
- Plexus Earnings Call Highlights Strong Growth Pipeline
- Plexus: Strong Fiscal 2026 Start and Upgraded Outlook Support Raised Buy Rating and $206 Price Target
- Plexus reports Q1 adjusted EPS $1.78, consensus $1.73
- Plexus sees Q2 EPS $1.80-$1.95, consensus $1.76
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
